These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26649645)

  • 21. Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.
    Nickels S; Vrieling A; Seibold P; Heinz J; Obi N; Flesch-Janys D; Chang-Claude J
    PLoS One; 2013; 8(9):e75088. PubMed ID: 24086446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
    Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
    Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Am J Clin Nutr; 2015 Oct; 102(4):966-73. PubMed ID: 26354532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
    LeBlanc ES; Viscoli CM; Henrich JB
    J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
    Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
    Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort.
    Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC
    Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Menopausal hormonal therapy and breast cancer.].
    Bakhidze EV; Belyaeva AV; Berlev IV; Anisimov VN; Belyaev AM
    Adv Gerontol; 2021; 34(2):277-286. PubMed ID: 34245512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menopausal hormone therapy (HT) in patients with breast cancer.
    Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
    Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
    Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
    Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
    BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
    Izano M; Satariano WA; Hiatt RA; Braithwaite D
    Cancer Med; 2015 Feb; 4(2):315-24. PubMed ID: 25511535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
    Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
    Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammographic screening reduces risk of breast carcinoma recurrence.
    Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
    Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort.
    Obi N; Eulenburg C; Seibold P; Eilber U; Thöne K; Behrens S; Chang-Claude J; Flesch-Janys D
    Breast; 2018 Apr; 38():75-80. PubMed ID: 29248876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
    Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
    Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.
    Kolben T; Harbeck N; Wuerstlein R; Schubert-Fritschle G; Bauerfeind I; Schrodi S; Engel J
    Breast; 2015 Feb; 24(1):24-31. PubMed ID: 25543874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.
    Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.